These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 28668375)

  • 1. Transient receptor potential melastatin 2 channels (TRPM2) mediate neonatal hypoxic-ischemic brain injury in mice.
    Huang S; Turlova E; Li F; Bao MH; Szeto V; Wong R; Abussaud A; Wang H; Zhu S; Gao X; Mori Y; Feng ZP; Sun HS
    Exp Neurol; 2017 Oct; 296():32-40. PubMed ID: 28668375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GSK-3β inhibitor TDZD-8 reduces neonatal hypoxic-ischemic brain injury in mice.
    Huang S; Wang H; Turlova E; Abussaud A; Ji X; Britto LR; Miller SP; Martinez A; Sun HS; Feng ZP
    CNS Neurosci Ther; 2017 May; 23(5):405-415. PubMed ID: 28256059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective Effects of AG490 in Neonatal Hypoxic-Ischemic Brain Injury.
    Li F; Wong R; Luo Z; Du L; Turlova E; Britto LRG; Feng ZP; Sun HS
    Mol Neurobiol; 2019 Dec; 56(12):8109-8123. PubMed ID: 31190145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal K(ATP) channels mediate hypoxic preconditioning and reduce subsequent neonatal hypoxic-ischemic brain injury.
    Sun HS; Xu B; Chen W; Xiao A; Turlova E; Alibraham A; Barszczyk A; Bae CY; Quan Y; Liu B; Pei L; Sun CL; Deurloo M; Feng ZP
    Exp Neurol; 2015 Jan; 263():161-71. PubMed ID: 25448006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tideglusib, a chemical inhibitor of GSK3β, attenuates hypoxic-ischemic brain injury in neonatal mice.
    Wang H; Huang S; Yan K; Fang X; Abussaud A; Martinez A; Sun HS; Feng ZP
    Biochim Biophys Acta; 2016 Oct; 1860(10):2076-85. PubMed ID: 27378458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRPM7 Mediates Neuronal Cell Death Upstream of Calcium/Calmodulin-Dependent Protein Kinase II and Calcineurin Mechanism in Neonatal Hypoxic-Ischemic Brain Injury.
    Turlova E; Wong R; Xu B; Li F; Du L; Habbous S; Horgen FD; Fleig A; Feng ZP; Sun HS
    Transl Stroke Res; 2021 Feb; 12(1):164-184. PubMed ID: 32430797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRPM2 channel: A novel target for alleviating ischaemia-reperfusion, chronic cerebral hypo-perfusion and neonatal hypoxic-ischaemic brain damage.
    Mai C; Mankoo H; Wei L; An X; Li C; Li D; Jiang LH
    J Cell Mol Med; 2020 Jan; 24(1):4-12. PubMed ID: 31568632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRPM7 inhibitor carvacrol protects brain from neonatal hypoxic-ischemic injury.
    Chen W; Xu B; Xiao A; Liu L; Fang X; Liu R; Turlova E; Barszczyk A; Zhong X; Sun CL; Britto LR; Feng ZP; Sun HS
    Mol Brain; 2015 Feb; 8():11. PubMed ID: 25761704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel role of reactive oxygen species-activated Trp melastatin channel-2 in mediating angiogenesis and postischemic neovascularization.
    Mittal M; Urao N; Hecquet CM; Zhang M; Sudhahar V; Gao XP; Komarova Y; Ushio-Fukai M; Malik AB
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):877-87. PubMed ID: 25675998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient receptor potential melastatin subfamily member 2 cation channel regulates detrimental immune cell invasion in ischemic stroke.
    Gelderblom M; Melzer N; Schattling B; Göb E; Hicking G; Arunachalam P; Bittner S; Ufer F; Herrmann AM; Bernreuther C; Glatzel M; Gerloff C; Kleinschnitz C; Meuth SG; Friese MA; Magnus T
    Stroke; 2014 Nov; 45(11):3395-402. PubMed ID: 25236871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dependence of NMDA/GSK-3β mediated metaplasticity on TRPM2 channels at hippocampal CA3-CA1 synapses.
    Xie YF; Belrose JC; Lei G; Tymianski M; Mori Y; Macdonald JF; Jackson MF
    Mol Brain; 2011 Dec; 4():44. PubMed ID: 22188973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of transient receptor potential melastatin 2 (TRPM2) channels in visceral nociception and hypersensitivity.
    Matsumoto K; Takagi K; Kato A; Ishibashi T; Mori Y; Tashima K; Mitsumoto A; Kato S; Horie S
    Exp Neurol; 2016 Nov; 285(Pt A):41-50. PubMed ID: 27616276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRPM2 Channel Aggravates CNS Inflammation and Cognitive Impairment via Activation of Microglia in Chronic Cerebral Hypoperfusion.
    Miyanohara J; Kakae M; Nagayasu K; Nakagawa T; Mori Y; Arai K; Shirakawa H; Kaneko S
    J Neurosci; 2018 Apr; 38(14):3520-3533. PubMed ID: 29507145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRPV1 mediates astrocyte activation and interleukin-1β release induced by hypoxic ischemia (HI).
    Yang XL; Wang X; Shao L; Jiang GT; Min JW; Mei XY; He XH; Liu WH; Huang WX; Peng BW
    J Neuroinflammation; 2019 May; 16(1):114. PubMed ID: 31142341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective Effects of Duloxetine against Cerebral Ischemia-Reperfusion Injury via Transient Receptor Potential Melastatin 2 Inhibition.
    Toda T; Yamamoto S; Umehara N; Mori Y; Wakamori M; Shimizu S
    J Pharmacol Exp Ther; 2019 Feb; 368(2):246-254. PubMed ID: 30523061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen and PARP-1 regulation of TRPM2 channels after ischemic injury.
    Shimizu T; Macey TA; Quillinan N; Klawitter J; Perraud AL; Traystman RJ; Herson PS
    J Cereb Blood Flow Metab; 2013 Oct; 33(10):1549-55. PubMed ID: 23801245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GSK-3β inhibitor TWS119 alleviates hypoxic-ischemic brain damage via a crosstalk with Wnt and Notch signaling pathways in neonatal rats.
    Gao L; Yang L; Cui H
    Brain Res; 2021 Oct; 1768():147588. PubMed ID: 34310937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended therapeutic window of a novel peptide inhibitor of TRPM2 channels following focal cerebral ischemia.
    Shimizu T; Dietz RM; Cruz-Torres I; Strnad F; Garske AK; Moreno M; Venna VR; Quillinan N; Herson PS
    Exp Neurol; 2016 Sep; 283(Pt A):151-6. PubMed ID: 27317297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRPM2 mediates ischemic kidney injury and oxidant stress through RAC1.
    Gao G; Wang W; Tadagavadi RK; Briley NE; Love MI; Miller BA; Reeves WB
    J Clin Invest; 2014 Nov; 124(11):4989-5001. PubMed ID: 25295536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of TRPM2 by AG490 Is Neuroprotective in a Parkinson's Disease Animal Model.
    Ferreira AFF; Singulani MP; Ulrich H; Feng ZP; Sun HS; Britto LR
    Mol Neurobiol; 2022 Mar; 59(3):1543-1559. PubMed ID: 35000153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.